石四药集团(02005.HK)获执行董事兼主席兼行政总裁曲继广增持188万股

Group 1 - The core point of the news is that Qu Jiguang, the Executive Director, Chairman, and CEO of Stone Four Pharmaceutical Group, increased his shareholding by purchasing 1.88 million shares at an average price of HKD 3.0859 per share, totaling approximately HKD 5.8015 million [1] - Following this transaction, Qu Jiguang's total shareholding increased to 1,171,742,000 shares, raising his ownership percentage from 39.64% to 39.70% [1][2] Group 2 - The transaction occurred on September 5, 2025, and was disclosed in the latest equity disclosure documents from the Hong Kong Stock Exchange [1] - The average price per share for the purchase was HKD 3.0859, indicating a strategic investment by the executive [2]